Endotronix, Inc.
Clinical trials sponsored by Endotronix, Inc., explained in plain language.
Medical device company developing remote monitoring for heart failure.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New implant lets heart patients check pressure from home
Disease control OngoingThis study tests a small sensor implanted in the lung artery that sends daily pressure readings to doctors. It involves 81 adults with advanced heart failure (NYHA Class III). The goal is to see if the device is safe and accurate, helping patients avoid hospital stays by catching…
Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Tiny lung sensor could keep heart failure patients out of the hospital
Disease control OngoingThis study tested a small sensor placed in the lung artery to help doctors monitor heart failure patients remotely. 738 people with advanced (NYHA Class III) heart failure took part. The goal was to see if using the sensor could reduce hospitalizations and deaths compared to a ta…
Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC